HealthQuill FDA
GE Healthcare has pulled out 688 medical systems that evaluate diseases, trauma, abnormalities and disorders, a move which USFDA termed a most severe type of recall.
Drugs Medical Pharma

GE Healthcare recalls 688 medical systems, FDA says ‘most serious’

GE Healthcare has pulled out 688 medical systems that evaluate diseases, trauma, abnormalities and disorders, a move which USFDA termed a most severe.

Read More
Lupin Limited, an Indian maker of branded, generic formulations, biotechnology products, and active pharmaceutical ingredients, has got USFDA approval for its ANDA injection, glycopyrrolate.
Drugs Pharma

Lupin gets FDA nod for injection to lessen saliva, stomach acidïżŒ

Lupin Limited, an Indian maker of branded, generic formulations, biotechnology products, and active pharmaceutical ingredients, has got USFDA approval for its ANDA injection,.

Read More
blue light filtering not beneficial for eye health
Drugs Pharma

Global Pharma recalls eye drops after FDA contamination warning

India-based Global Pharma Healthcare voluntarily recalled all lots of its artificial tears lubricant eye drops after the USFDA reported possible contamination.

Read More
GSK Plc., a British global pharmaceutical company, announced the FDA had approved an oral drug to treat anaemia arising from chronic kidney disease in patients who have been on dialysis for four months.
Drugs Medical Pharma

GSK Plc gets FDA nod to make oral drug for anaemic CKD patients

GSK Plc., a British global pharmaceutical company, announced the FDA had approved an oral drug to treat anaemia arising from chronic kidney disease.

Read More
Eli Lilly announced that it had received US FDA approval for a tablet to treat a rare form of blood cancer.
Drugs Medical Pharma

Eli Lilly gets FDA nod for blood cancer drug

Eli Lilly announced that it had received US FDA approval for a tablet to treat a rare form of blood cancer.

Read More
A recall of Swedish makers' of heart devices has been classified by the FDA as "most serious" since they could lead to severe injuries or death.
Drugs Medical Pharma

US health regulator says heart devices recall “most serious”

A recall of Swedish makers' of heart devices has been classified by the FDA as "most serious" since they could lead to severe.

Read More
Eli Lilly will invest an additional $450 million to expand its manufacturing capacity at Research Triangle Park facility in North Carolina.
Drugs Pharma

Eli Lilly plans $450 million extra to expand Research Triangle

Eli Lilly will invest an additional $450 million to expand its manufacturing capacity at Research Triangle Park facility in North Carolina.

Read More
Dr. Reddy's Meloma Patent antitrust law
Drugs Pharma

USFDA grants ‘tentative approval’ to Zydus’ mental health drug

The USFDA has granted Zydus Lifesciences Limited ‘tentative approval’ to market Levomilnacipran extended-release capsules in 20 mg, 40 mg, 80 mg, and 120.

Read More
Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.
Drugs Pharma

Eiasi files market authorization for Alzheimer’s drug in JapanïżŒ

Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.

Read More
Indian drug major Sun Pharmaceutical’s western Indian facility of Halal has been issued a warning letter by the FDA for not conforming to Current Good Manufacturing Practices (CGMP).
Drugs Pharma

US drug regulator issues warning letter to Sun Pharma on CGMP

Indian drug major Sun Pharmaceutical’s western Indian facility of Halal has been issued a warning letter by the FDA for not conforming to Current Good.

Read More